Cold Agglutinin Disease Drugs Market is segmented By Treatment Approach (Rituximab monotherapy, Corticosteroids, Biologics like ENJAYMO), By Pipeline Drugs (Iptacopan, Parsaclisib, Pegcetacoplan), By Type of Disease (Primary Cold Agglutinin Disease, Secondary Cold Agglutinin Disease), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.